Garber, A <br/><br/>
Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Mar 2006 
 - 156-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1462-8902 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2005.00570.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Glucose--metabolism<br/>Body Weight<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Fasting--blood<br/>Female<br/>Glyburide--administration & dosage<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemia--etiology<br/>Hypoglycemic Agents--administration & dosage<br/>Lipid Metabolism<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Rosiglitazone<br/>Tablets<br/>Thiazolidinediones--administration & dosage<br/>Treatment Outcome